Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Trial of BINTRAFUSP ALFA (M7824) and Pimasertib for Treatment of Intracranial Metastases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04789668
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:11.981426+00:00
Published At
2026-03-18T00:00:00+00:00
Record Updated At
2026-03-18
Results Posted At
2026-03-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Anatomic Stage IV Breast Cancer AJCC v8", "Clinical Stage IV Cutaneous Melanoma AJCC v8", "Hematopoietic and Lymphoid Cell Neoplasm", "Hormone Receptor Positive Breast Adenocarcinoma", "Metastatic Lung Non-Small Cell Carcinoma", "Metastatic Malignant Neoplasm in the Brain", "Metastatic Malignant Solid Neoplasm", "Metastatic Melanoma", "Metastatic Triple-Negative Breast Carcinoma", "Pathologic Stage IV Cutaneous Melanoma AJCC v8", "Prognostic Stage IV Breast Cancer AJCC v8", "Stage IV Lung Cancer AJCC v8", "Stage IVA Lung Cancer AJCC v8", "Stage IVB Lung Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-18"
protocolSection.identificationModule.nctId
"NCT04789668"
protocolSection.identificationModule.officialTitle
"Phase I/II Trial of BINTRAFUSP ALFA (M7824) and Pimasertib for Treatment of Intracranial Metastases"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-03-18"

Study condition terms

  • Anatomic Stage IV Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IV Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Hematopoietic and Lymphoid Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Hormone Receptor Positive Breast Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Neoplasm in the Brain (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Melanoma (protocolSection.conditionsModule.conditions)
  • Metastatic Triple-Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Prognostic Stage IV Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.